“We need you to make sure the arthritis patient voice is heard at the U.S. Food and Drug Administration (FDA)!” affirmed Suz Schrandt, the Arthritis Foundation’s director of patient engagement, in a patients’ call to action.
Making sure the patient voice is heard is a top priority for the Arthritis Foundation – and we are not alone. Our partners at the Clinical Trials Transformation Initiative (CTTI), in collaboration with the FDA, will be hosting a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials,” on March 18, 2019, in Silver Spring, Maryland.
The purpose of the public workshop is to obtain the perspectives of patients, caregivers, industry representatives, academic researchers and other experts on:
- Challenges and barriers to patients taking part in clinical trials
- Best practices and key considerations for incorporating patient perspectives in clinical trial access, design, conduct and post-trial follow-up.
“We know that patients and patient advocates play a key role in making trials more efficient, effective and patient-centered,” says Pamela Tenaerts, executive director of CTTI. “This is an excellent opportunity for patients, investigators and other groups to have their voices heard and, ultimately, help shape better clinical trials.”
A published report on proceedings and recommendations from the workshop will be made public. Register online to attend the workshop. Registration is free and based on space availability, with priority given to early registrants. There’s also the option of watching the workshop live via webcast. The deadline to register is March 11, 2019.
The Arthritis Foundation is one of more than 80 organizations collaborating through CTTI. Some of our current joint projects include Mobile Clinical Trials and Real World Evidence.